- Home
- GTBP vs DEVS Comparison
GTBP vs DEVS Comparison
Compare GTBP & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- DEVS
- Stock Information
- Founded
- GTBP 1965
- DEVS N/A
- Country
- GTBP United States
- DEVS Canada
- Employees
- GTBP N/A
- DEVS N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- DEVS
- Sector
- GTBP Health Care
- DEVS
- Exchange
- GTBP Nasdaq
- DEVS NYSE
- Market Cap
- GTBP 5.5M
- DEVS 6.4M
- IPO Year
- GTBP N/A
- DEVS N/A
- Fundamental
- Price
- GTBP $2.28
- DEVS $0.19
- Analyst Decision
- GTBP Strong Buy
- DEVS
- Analyst Count
- GTBP 1
- DEVS 0
- Target Price
- GTBP $11.00
- DEVS N/A
- AVG Volume (30 Days)
- GTBP 14.8K
- DEVS 266.2K
- Earning Date
- GTBP 05-14-2025
- DEVS 05-12-2025
- Dividend Yield
- GTBP N/A
- DEVS N/A
- EPS Growth
- GTBP N/A
- DEVS N/A
- EPS
- GTBP N/A
- DEVS N/A
- Revenue
- GTBP N/A
- DEVS N/A
- Revenue This Year
- GTBP N/A
- DEVS N/A
- Revenue Next Year
- GTBP N/A
- DEVS N/A
- P/E Ratio
- GTBP N/A
- DEVS N/A
- Revenue Growth
- GTBP N/A
- DEVS N/A
- 52 Week Low
- GTBP $1.72
- DEVS $0.18
- 52 Week High
- GTBP $10.66
- DEVS $1.91
- Technical
- Relative Strength Index (RSI)
- GTBP 48.56
- DEVS N/A
- Support Level
- GTBP $2.15
- DEVS N/A
- Resistance Level
- GTBP $2.38
- DEVS N/A
- Average True Range (ATR)
- GTBP 0.17
- DEVS 0.00
- MACD
- GTBP -0.01
- DEVS 0.00
- Stochastic Oscillator
- GTBP 32.35
- DEVS 0.00
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About DEVS DEVVSTREAM CORP
DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.